Advanced search
Publication Cover
Current Medical Research and Opinion Volume 26, 2010 - Issue 1
Submit an article Journal homepage
183
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Benefits and risks of raloxifene by vertebral fracture status

Angelina Sontag Lilly USA, LLC, Indianapolis, IN, USA
,
Xiaohai Wan Lilly USA, LLC, Indianapolis, IN, USA
&
John H. Krege Lilly USA, LLC, Indianapolis, IN, USACorrespondence[email protected]
Pages 71-76 | Accepted 20 Oct 2009, Published online: 12 Nov 2009

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Raymond E. Cole. (2011) Clinical Strategies to Address Patients' Concerns in Osteoporosis Management with Bisphosphonates. Postgraduate Medicine 123:2, pages 131-144.
Read now

Articles from other publishers (9)

G. Porcu, A. Biffi, R. Ronco, G. Adami, R. Alvaro, R. Bogini, A. P. Caputi, B. Frediani, D. Gatti, S. Gonnelli, G. Iolascon, A. Lenzi, S. Leone, R. Michieli, S. Migliaccio, T. Nicoletti, M. Paoletta, A. Pennini, E. Piccirilli, M. Rossini, U. Tarantino, L. Cianferotti, M. L. Brandi & G. Corrao. (2023) Refracture following vertebral fragility fracture when bone fragility is not recognized: summarizing findings from comparator arms of randomized clinical trials. Journal of Endocrinological Investigation.
Crossref
Mina Nicole Händel, Isabel Cardoso, Cecilie von Bülow, Jeanett Friis Rohde, Anja Ussing, Sabrina Mai Nielsen, Robin Christensen, Jean-Jacques Body, Maria Luisa Brandi, Adolfo Diez-Perez, Peyman Hadji, Muhammad Kassim Javaid, Willem Frederik Lems, Xavier Nogues, Christian Roux, Salvatore Minisola, Andreas Kurth, Thierry Thomas, Daniel Prieto-Alhambra, Serge Livio Ferrari, Bente Langdahl & Bo Abrahamsen. (2023) Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials. BMJ, pages e068033.
Crossref
Giovanni Corrao, Annalisa Biffi, Gloria Porcu, Raffaella Ronco, Giovanni Adami, Rosaria Alvaro, Riccardo Bogini, Achille Patrizio Caputi, Luisella Cianferotti, Bruno Frediani, Davide Gatti, Stefano Gonnelli, Giovanni Iolascon, Andrea Lenzi, Salvatore Leone, Raffaella Michieli, Silvia Migliaccio, Tiziana Nicoletti, Marco Paoletta, Annalisa Pennini, Eleonora Piccirilli, Maurizio Rossini, Umberto Tarantino & Maria Luisa Brandi. (2023) Executive summary: Italian guidelines for diagnosis, risk stratification, and care continuity of fragility fractures 2021. Frontiers in Endocrinology 14.
Crossref
Chelsea Ayers, Devan KansagaraBrittany LazurRongwei FuAmy Kwon & Curtis Harrod. (2023) Effectiveness and Safety of Treatments to Prevent Fractures in People With Low Bone Mass or Primary Osteoporosis: A Living Systematic Review and Network Meta-analysis for the American College of Physicians. Annals of Internal Medicine 176:2, pages 182-195.
Crossref
Howard A. FinkRoderick MacDonaldMary L. ForteChristina E. RosebushKristine E. EnsrudJohn T. SchousboeVictoria A. NelsonKristen UllmanMary ButlerCarin M. OlsonBrent C. TaylorMichelle BrasureTimothy J. Wilt. (2019) Long-Term Drug Therapy and Drug Discontinuations and Holidays for Osteoporosis Fracture Prevention. Annals of Internal Medicine 171:1, pages 37.
Crossref
Meera Viswanathan, Shivani Reddy, Nancy Berkman, Katie Cullen, Jennifer Cook Middleton, Wanda K. Nicholson & Leila C. Kahwati. (2018) Screening to Prevent Osteoporotic Fractures. JAMA 319:24, pages 2532.
Crossref
T. Saito, J. M. Sterbenz, S. Malay, L. Zhong, M. P. MacEachern & K. C. Chung. (2017) Effectiveness of anti-osteoporotic drugs to prevent secondary fragility fractures: systematic review and meta-analysis. Osteoporosis International 28:12, pages 3289-3300.
Crossref
Özgur Ismailoglu, Baha Oral, Önder Tomruk, Recep Sütcü, Yusuf Kara & Necdet Demir. (2013) Neuroprotective Effects of Raloxifene on Experimental Spinal Cord Injury in Rats. The American Journal of the Medical Sciences 345:1, pages 39-44.
Crossref
. (2010) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 19:7.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.